Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Liver Diseases

Free Subscription 31.10.2022 2 AJR Am J Roentgenol 9 Anticancer Res 2 Biochem Biophys Res Commun 1 BMC Cancer 1 Br J Surg 1 Dig Dis 4 Dig Dis Sci 1 Endoscopy 3 Gastroenterology 1 Gut 1 Hepatology 1 J Gastroenterol 1 J Gastroenterol Hepatol 1 J Hepatol 1 Nat Rev Cancer 1 Oncogene 1 Proc Natl Acad Sci U S A 2 Radiology 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. BARR RG
   Editorial Comment: How Imaging Can Manage the Fatty Liver Epidemic.
   AJR Am J Roentgenol. 2022 Jun 22. doi: 10.2214/AJR.22.28113.
   PubMed        
   
   
2. TSE JR, Shen L, Bird KN, Yoon L, et al
   Outcomes of LI-RADS US-2 Subthreshold Observations Detected on Surveillance Ultrasound.
   AJR Am J Roentgenol. 2022 Jun 15. doi: 10.2214/AJR.22.27812.
   PubMed         Abstract available
   
   

   
   Anticancer Res

3. TAKEDA S, Namisaki T, Tsuji Y, Fujimoto Y, et al
   Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective Study.
   Anticancer Res. 2022;42:5465-5473.
   PubMed         Abstract available
   
   
4. TAKEDA K, Kikuchi Y, Sawada YU, Kumamoto T, et al
   Efficacy of Adjuvant Chemotherapy Following Curative Resection of Colorectal Cancer Liver Metastases.
   Anticancer Res. 2022;42:5497-5505.
   PubMed         Abstract available
   
   
5. YUEH TC, Tsao HY, Chien WC, Tsai CW, et al
   The Contribution of Matrix Metalloproteinase-7 Promoter Genotypes to Hepatocellular Carcinoma Susceptibility.
   Anticancer Res. 2022;42:5275-5282.
   PubMed         Abstract available
   
   
6. HUANG G, Howard LN, Alonsozana E, Sill D, et al
   Molecular Characteristics and Immunogenomic Profiling of Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma in a 68-year-old Patient.
   Anticancer Res. 2022;42:5475-5478.
   PubMed         Abstract available
   
   
7. SASAKI T, Shigeta K, Kitahara S, Suzuki Y, et al
   Inhibition of STAT3 Promotes Effector T Cell Infiltration But also Immunosuppression in the HCC Tumor Microenvironment.
   Anticancer Res. 2022;42:5205-5215.
   PubMed         Abstract available
   
   
8. SCHMITZ V, Bauerschmitz G, Gallwas J, Grundker C, et al
   Suppression of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances the Anti-invasive Efficacy of Selective ERbeta Agonists.
   Anticancer Res. 2022;42:5187-5194.
   PubMed         Abstract available
   
   
9. KIM SH, Song SE, Baik H, Hur DY, et al
   15-Prostaglandin Dehydrogenase Inhibition Enhances Colon Cancer Metastasis by Up-regulation of Epithelial-to-Mesenchymal Transition Genes.
   Anticancer Res. 2022;42:5385-5396.
   PubMed         Abstract available
   
   
10. KOMATSU S, Yano Y, Kido M, Kuramitsu K, et al
    Rechallenge With Lenvatinib After Atezolizumab Plus Bevacizumab Treatment for Hepatocellular Carcinoma.
    Anticancer Res. 2022;42:5479-5486.
    PubMed         Abstract available
    
    
11. YAMAMURA K, Beppu T, Inoue K, Matsumura K, et al
    Vater Papilla-preserving Strategy for Advanced Hepatocellular Carcinoma With Excessive Bile Duct Tumor Thrombus.
    Anticancer Res. 2022;42:5663-5670.
    PubMed         Abstract available
    
    

    
    Biochem Biophys Res Commun

12. SAMERI MJ, Savari F, Hoseinynejad K, Danyaei A, et al
    The hepato-protective effect of H2S-modified and non-modified mesenchymal stem cell exosomes on liver ischemia-reperfusion injury in mice: The role of MALAT1.
    Biochem Biophys Res Commun. 2022;635:194-202.
    PubMed         Abstract available
    
    
13. ZHANG F, Wu J, Ruan H, Xia J, et al
    ZeXie decoction alleviates non-alcoholic fatty liver disease in rats: the study of genes, lipids, and gut microbiotas.
    Biochem Biophys Res Commun. 2022;632:129-138.
    PubMed         Abstract available
    
    

    
    BMC Cancer

14. MO M, Ma X, Luo Y, Tan C, et al
    Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma.
    BMC Cancer. 2022;22:1098.
    PubMed         Abstract available
    
    

    
    Br J Surg

15. LOPEZ-LOPEZ V, Sanchez-Esquer I, Crespo MJ, Navarro MA, et al
    Development and validation of advanced three-dimensional navigation device integrated in da Vinci Xi(R) surgical robot for hepatobiliary surgery: pilot study.
    Br J Surg. 2022 Oct 26. pii: 6775136. doi: 10.1093.
    PubMed        
    
    

    
    Dig Dis

16. WANG X, Zhang J, Luo F, Shen Y, et al
    Application of CircRNA Circ_0071662 in the diagnosis and prognosis of hepatocellular carcinoma and its response to radiotherapy.
    Dig Dis. 2022 Oct 24. pii: 000527696. doi: 10.1159/000527696.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

17. CARDOSO AC, Tovo CV, Leite NC, El Bacha IA, et al
    Validation and Performance of FibroScan(R)-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:5272-5279.
    PubMed         Abstract available
    
    
18. YEBOAH-KORANG A, Memon A, Patel N, Portocarrero-Castillo A, et al
    Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults.
    Dig Dis Sci. 2022;67:5262-5271.
    PubMed         Abstract available
    
    
19. SARAIREH H, Abdelfattah T, Hassouneh R, Lippman R, et al
    "Wet Heparin" and "Wet Saline" EUS-Guided Liver Biopsy Techniques Both Provide High Rates of Specimen Adequacy for Benign Parenchymal Liver Disease.
    Dig Dis Sci. 2022;67:5256-5261.
    PubMed         Abstract available
    
    
20. TAPPER EB, Zhao Z, Mazumder N, Parikh ND, et al
    Incidence of, Risk Factors for, and Outcomes After Ascites in a Population-Based Cohort of Older Americans.
    Dig Dis Sci. 2022;67:5327-5335.
    PubMed         Abstract available
    
    

    
    Endoscopy

21. OGURA T, Uba Y, Yamamura M, Kawai J, et al
    Successful endoscopic ultrasound-guided hepaticogastrostomy with use of a novel drill dilator for challenging tract dilation.
    Endoscopy. 2022 Oct 28. doi: 10.1055/a-1956-0763.
    PubMed        
    
    

    
    Gastroenterology

22. BLAIR AB, Wang J, Davelaar J, Baker A, et al
    Dual stromal targeting sensitizes pancreatic adenocarcinoma for anti-PD-1 therapy.
    Gastroenterology. 2022 Jun 16. pii: S0016-5085(22)00645.
    PubMed         Abstract available
    
    
23. PRASOPPOKAKORN T, Rerknimitr R
    An Unusual Complication of Endoscopic Cyanoacrylate Injection for Gastric Varix.
    Gastroenterology. 2022;163:1186-1187.
    PubMed        
    
    
24. MAGAHIS P, Rosenblatt R, Mahadev S
    An Unusual Cause of Right Upper Quadrant Pain With Abnormal Liver Enzymes.
    Gastroenterology. 2022;163:e3-e5.
    PubMed        
    
    

    
    Gut

25. ZHAO Y, Yeo YH, Samaan J, Lv F, et al
    Most excess years of potential life loss among individuals with cirrhosis during the pandemic were not related to COVID-19.
    Gut. 2022 Sep 5. pii: gutjnl-2022-328188. doi: 10.1136/gutjnl-2022-328188.
    PubMed        
    
    

    
    Hepatology

26. 
    Erratum for Jiang L, et al. calcium-binding protein 39 promotes hepatocellular carcinoma growth and metastasis by activating extracellular signal-regulated kinase signaling pathway.
    Hepatology. 2022 Oct 26. doi: 10.1002/hep.32796.
    PubMed        
    
    

    
    J Gastroenterol

27. LIN YC, Lin HF, Wu CC, Chen CL, et al
    Pathogenic effects of Desulfovibrio in the gut on fatty liver in diet-induced obese mice and children with obesity.
    J Gastroenterol. 2022;57:913-925.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

28. GORGANI F, Esfahani Z, Ghamari SH, Ghasemi E, et al
    Global, Regional, and National Burden and Quality of Care Index of Liver Cirrhosis by Cause from Global Burden of Disease 1990-2019.
    J Gastroenterol Hepatol. 2022 Oct 26. doi: 10.1111/jgh.16041.
    PubMed         Abstract available
    
    

    
    J Hepatol

29. PRYKE R, Guha IN
    Time to focus chronic liver diseases back into the community: A review of primary care hepatology tools, pathways of care and reimbursement mechanisms.
    J Hepatol. 2022 Oct 22. pii: S0168-8278(22)03146.
    PubMed         Abstract available
    
    

    
    Nat Rev Cancer

30. SENFT D
    Platelets limit liver tumours.
    Nat Rev Cancer. 2022;22:608.
    PubMed        
    
    

    
    Oncogene

31. PAN Z, Liu C, Zhi Y, Xie Z, et al
    LIMK1 nuclear translocation promotes hepatocellular carcinoma progression by increasing p-ERK nuclear shuttling and by activating c-Myc signalling upon EGF stimulation.
    Oncogene. 2021;40:2581-2595.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

32. ZHOU Q, Kang G, Jiang P, Qiao R, et al
    Epigenetic analysis of cell-free DNA by fragmentomic profiling.
    Proc Natl Acad Sci U S A. 2022;119:e2209852119.
    PubMed         Abstract available
    
    

    
    Radiology

33. FETZER DT, Rosado-Mendez IM, Wang M, Robbin ML, et al
    Pulse-Echo Quantitative US Biomarkers for Liver Steatosis: Toward Technical Standardization.
    Radiology. 2022;305:265-276.
    PubMed         Abstract available
    
    
34. CASSINOTTO C, Jacq T, Anselme S, Ursic-Bedoya J, et al
    Diagnostic Performance of Attenuation to Stage Liver Steatosis with MRI Proton Density Fat Fraction as Reference: A Prospective Comparison of Three US Machines.
    Radiology. 2022 Jul 12:212846. doi: 10.1148/radiol.212846.
    PubMed         Abstract available
    
    

    
    Transplantation

35. TEJEDOR M, Selzner N, Berenguer M
    Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List?
    Transplantation. 2022 May 16. pii: 00007890-990000000-00049.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: